FibroGen (NASDAQ:FGEN) Now Covered by StockNews.com

Dec 9, 2024 · FGEN opened at $0.34 on Friday. FibroGen has a twelve month low of $0.18 and a twelve month high of $2.93. The firm has a market cap of $34.47 million, a price-to-earnings …

$0.34
OFF

FibroGen (NASDAQ:FGEN) Now Covered By StockNews.com

2 weeks from now

Dec 9, 2024 · FGEN opened at $0.34 on Friday. FibroGen has a twelve month low of $0.18 and a twelve month high of $2.93. The firm has a market cap of $34.47 million, a price-to-earnings …

etfdailynews.com

$47000
OFF

FibroGen (NASDAQ:FGEN) Coverage Initiated By Analysts At …

2 weeks from now

Jan 1, 2025 · Point72 DIFC Ltd now owns 52,254 shares of the biopharmaceutical company's stock valued at $47,000 after buying an additional 45,990 shares during the period. Doheny …

marketbeat.com

$0.42
OFF

FibroGen (NASDAQ:FGEN) Coverage Initiated By Analysts At …

2 weeks from now

Nov 30, 2024 · Shares of NASDAQ:FGEN opened at $0.42 on Friday. FibroGen has a 52-week low of $0.18 and a 52-week high of $2.93. The firm has a market capitalization of $42.80 …

defenseworld.net

25%
OFF

FibroGen (Nasdaq:FGEN) - Stock Price, News & Analysis - Simply …

2 weeks from now

Jan 6, 2025 · Research FibroGen's (Nasdaq:FGEN) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more. ... Now 25% …

simplywall.st

$0.33
OFF

FibroGen (NASDAQ:FGEN) Now Covered By StockNews.com

2 weeks from now

Dec 17, 2024 · Shares of FibroGen stock opened at $0.33 on Monday. The business has a fifty day simple moving average of $0.35 and a 200-day simple moving average of $0.59. …

etfdailynews.com

$284.23
OFF

FibroGen (FGEN) Earnings Date And Reports 2025 - MarketBeat

2 weeks from now

Jan 3, 2025 · FibroGen (NASDAQ:FGEN) has a recorded net income of -$284.23 million. FGEN has generated -$1.23 earnings per share over the last four quarters. ... Act Now. Altcoin …

marketbeat.com

1%
OFF

Geode Capital Management LLC Boosts Stock Position In …

2 weeks from now

2 days ago · Geode Capital Management LLC raised its holdings in shares of FibroGen, Inc. (NASDAQ:FGEN – Free Report) by 3.1% in the 3rd quarter, according to the company in its …

etfdailynews.com

FAQs about FibroGen (NASDAQ:FGEN) Now Covered by StockNews.com Coupon?

Is FibroGen (fgen) a good stock to buy?

StockNews.com started coverage on shares of FibroGen (NASDAQ:FGEN – Free Report) in a research report sent to investors on Sunday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Separately, William Blair reaffirmed a “market perform” rating on shares of FibroGen in a research report on Wednesday, November 13th. ...

Is FibroGen a'market perform' stock?

StockNews.com started coverage on shares of FibroGen (NASDAQ:FGEN – Free Report) in a research note issued to investors on Monday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Separately, William Blair restated a “market perform” rating on shares of FibroGen in a report on Wednesday, November 13th. ...

Should you buy FibroGen (FibroGen)?

StockNews.com began coverage on FibroGen in a research report on Wednesday, January 1st. They set a “hold” rating on the stock. HC Wainwright upgraded shares of FibroGen to a “strong-buy” rating in a research report on Tuesday, December 17th. ...

Who owns FibroGen stock?

Only 1.98% of the stock of FibroGen is held by insiders. 72.71% of the stock of FibroGen is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Read more about FibroGen's insider trading history. Receive FGEN Stock News and Ratings via Email ...

When did FibroGen (fgen) announce earnings?

FibroGen (NASDAQ:FGEN – Get Free Report) last announced its earnings results on Tuesday, November 12th. The biopharmaceutical company reported ($0.17) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.38) by $0.21. ...

How much does FibroGen (fgen) cost?

The company has a 50 day moving average price of $0.36 and a two-hundred day moving average price of $0.55. FibroGen (NASDAQ:FGEN – Get Free Report) last posted its quarterly earnings results on Tuesday, November 12th. The biopharmaceutical company reported ($0.17) EPS for the quarter, beating the consensus estimate of ($0.38) by $0.21. ...